Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pancreatin Enteric-Coated Capsules 25000 vs 10000 in PEI (China) – CFA Equivalence
CTR20170260Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Apr 2017
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes, Blood Coagulation Factors → Therapeutic Enzymes → Recombinant Proteins and Enzymes, Insulin and Analogs → Hormones & Growth Factors → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of pancreatin in exocrine pancreatic insufficiency (EPI), sponsored by Abbott Laboratories. Started Apr 2017; status: completed.
02
Drugs
pancreatin
03
Conditions
exocrine pancreatic insufficiency (EPI)
Beyond the preview
Go deeper on CTR20170260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170260.